Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
165M
-
Shares change
-
+12.4M
-
Total reported value, excl. options
-
$545M
-
Value change
-
+$39M
-
Put/Call ratio
-
1.1
-
Number of buys
-
85
-
Number of sells
-
-58
-
Price
-
$3.31
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q1 2023
184 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q1 2023.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 165M shares
of 237M outstanding shares and own 69.52% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.4M shares), STATE STREET CORP (13M shares), PERCEPTIVE ADVISORS LLC (11.9M shares), VANGUARD GROUP INC (11.8M shares), Nuveen Asset Management, LLC (9.03M shares), D. E. Shaw & Co., Inc. (8.21M shares), Stonepine Capital Management, LLC (7.66M shares), Magnetar Financial LLC (7.07M shares), Assenagon Asset Management S.A. (6.67M shares), and AWM Investment Company, Inc. (6.02M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.